SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler

Since December 2019, the Coronavirus Disease 2019 (COVID-19) pandemic has become a non-neglectable context for the whole healthcare system. Under the background of COVID-19, the detection and diagnosis of malaria cases are under challenge. Here, we reported a COVID-19 and malaria co-infection travel...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Huang (Author), Wen-Jie Xu (Author), Xiao-Xiao Wang (Author), Xuan Zhang (Author), Ke-Nu Pan (Author), Jia-Qi Zhang (Author), Hua-Liang Chen (Author), Wei Ruan (Author), Li-Nong Yao (Author)
Format: Book
Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a28a16a8a3a44fff94c29771d12fa7f9
042 |a dc 
100 1 0 |a Qian Huang  |e author 
700 1 0 |a Wen-Jie Xu  |e author 
700 1 0 |a Xiao-Xiao Wang  |e author 
700 1 0 |a Xuan Zhang  |e author 
700 1 0 |a Ke-Nu Pan  |e author 
700 1 0 |a Jia-Qi Zhang  |e author 
700 1 0 |a Hua-Liang Chen  |e author 
700 1 0 |a Wei Ruan  |e author 
700 1 0 |a Li-Nong Yao  |e author 
245 0 0 |a SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler 
260 |b Frontiers Media S.A.,   |c 2022-08-01T00:00:00Z. 
500 |a 2296-2565 
500 |a 10.3389/fpubh.2022.871374 
520 |a Since December 2019, the Coronavirus Disease 2019 (COVID-19) pandemic has become a non-neglectable context for the whole healthcare system. Under the background of COVID-19, the detection and diagnosis of malaria cases are under challenge. Here, we reported a COVID-19 and malaria co-infection traveler who has a long living history in Cameroon. The case was administered with dihydroartemisinin and piperaquine tablets for malaria, Lopinavir and Ritonavir tablets, Arbidol, recombinant human interferon α-2b and Compound Maxing Yifei mixture for COVID-19, and Zolpidem Tartrate tablets, Diazepam, Paroxetine Hydrochloride tablets, Thymosin α1, and Lianhua Qinwen Jiaonang during the second hospitalization of the patient since the patient has a certain level of anxiety and insomnia with no evidence of inflammatory reactions. After being tested negative two times for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 48 h, the patient met China's COVID-19 discharge standards and was discharged with stable vital signs and mental state. Since most countries in the sub-Saharan region have a fragile health system, co-infection for both Plasmodium and SARS-CoV-2 may not be uncommon, and raise a challenge in diagnosis, treatment, and prevention for both diseases. We add to the literature on co-infection of P. falciparum malaria and COVID-19 and offer operational advice on diagnosis, prevention, and treatment for the co-infection. 
546 |a EN 
690 |a COVID-19 
690 |a Sub-Saharan Africa 
690 |a co-infection 
690 |a Plasmodium falciparum 
690 |a malaria 
690 |a SARS-CoV-2 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Frontiers in Public Health, Vol 10 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fpubh.2022.871374/full 
787 0 |n https://doaj.org/toc/2296-2565 
856 4 1 |u https://doaj.org/article/a28a16a8a3a44fff94c29771d12fa7f9  |z Connect to this object online.